Juvenile Diabetes Research Foundation hosts annual event
WELLESLEY, Mass. The New England Chapter of the Juvenile Diabetes Research Foundation hopes to raise $1.5 million with a black-tie gala Saturday.
The chapter’s Massachusetts branch will have its 27th annual Hearts & Heroes Gala at the Boston Marriott Copley Place, paying tribute to Insulet Corp. president and CEO Duane DeSisto as honoree and giving the Nancy Jones Diabetes Champion Award to Massachusetts Sen. Edward Kennedy.
“In the fight against diabetes, we have one vision: to find a cure,” JDRF New England Chapter executive director Heidi Daniels said in a statement. “Duane DeSisto, Insulet Corp. and Sen. Kennedy are true champions in the hearts and minds of all of us with loved ones who have Type 1 diabetes.”
Cardiac issues seen in patients with poorly controlled diabetes
ALEXANDRIA, Va. A study included in the May 2009 journal Diabetes Care, a journal published by the American Diabetes Association, demonstrated preclinical abnormalities of cardiac structure and function in adolescent girls with Type 2 diabetes, despite the short duration of diabetes.
The learnings highlight the potential high cardiovascular risk occurring in adolescent Type 2 diabetes, the authors concluded.
As part of the research, 19 adolescent girls were recruited, eight with Type 2 diabetes and 11 with Type 1 diabetes, from a hospital diabetes service and 20 control subjects without diabetes from the schools of the diabetic subjects.
The groups were similar in age and height, but significant differences in body composition were observed. Subjects with Type 2 diabetes had larger left ventricular dimensions and left ventricular mass, which persisted when indexed to height. Diastolic filling was impaired in both diabetic groups, and systolic longitudinal function was lower in the Type 2 diabetic group. Half of the group with Type 2 diabetes met the published criteria for LVH and left ventricular dilatation; 25% had evidence of elevated left ventricular filling pressure in association with structural abnormalities.
Roche launches complete detection kit for influenza A /H1N1
PENZBERG, Germany Roche Applied Science on Thursday announced the availability of a new detection kit for the novel influenza A/H1N1 virus. Roche currently is filing to get approval of the local health authorities worldwide for use of the kit in emergency situations.
“The design of the new detection kits benefited very much from information we got out of our manifold research cooperations,” stated Manfred Baier, head of Roche Applied Science. “We are glad of our contribution in supplying fast and reliable tools for the detection of Influenza A/H1N1 to the research community.”
Currently, there is no human vaccine on the market that protects against Influenza A H1N1 infection, Roche noted. Standard therapy for the disease includes treatment with antiviral drugs like Tamiflu or Relenza.